retatrutide clinical trial weight loss results trials 🚨 BREAKING: Shows “Bariatric-Level” in Phase 3 New Phase III retatrutide study demonstrates

Accessed Apr 14, 2025

A two-week stretch of poor sleep or high stress can stall weight loss entirely, independent of diet and medication adherence

Arch Intern Med1969 Mar;123(3):261-6

Standard protocols appear well-tolerated in this demographic, with the 15-year follow-up study providing reassurance about long-term use in older individuals

In addition, we observed a reduction of KLF2 along with ERK5 degradation, which is a known downstream target gene of ERK5 (Fig

This is a mechanism no approved drug currently uses Phase 2 trials showed up to 24% body weight reduction over 48 weeks, meaningfully exceeding tirzepatide and semaglutide outcomes Phase 3 trials are currently underway